Vivos Therapeutics (VVOS) EBIT Margin (2020 - 2026)
Vivos Therapeutics (VVOS) reported EBIT Margin of 128.67% for Q1 2026, up 124.0% year-over-year from 57.44% in Q1 2025, and up 22.9% on a QoQ basis from 166.89% in Q4 2025.
Vivos Therapeutics (VVOS) has 7 years of EBIT Margin data on file, last reported at 128.67% in Q1 2026.
- Quarterly EBIT Margin rose 124.0% year-over-year to 128.67% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 115.47% (down 3819.0% YoY) and the FY2025 annual result came in at 114.05%, down 3973.0% from the prior year.
- EBIT Margin advanced to 128.67% in Q1 2026 per VVOS's latest filing, from 166.89% in the prior quarter.
- Across five years, EBIT Margin topped out at 47.76% in Q2 2024 and bottomed at 182.19% in Q1 2022.
- The 5-year median for EBIT Margin is 127.36% (2025), against an average of 120.9%.
- The widest annual swing landed in 2022, when EBIT Margin plunged 35172 bps; it then soared 8529 bps in 2024.
- Tracing VVOS's EBIT Margin over 5 years: stood at 153.49% in 2022, then increased by 17 bps to 127.25% in 2023, then surged by 40 bps to 75.88% in 2024, then tumbled by 120 bps to 166.89% in 2025, then advanced by 23 bps to 128.67% in 2026.
- Per Business Quant, the three latest VVOS EBIT Margin figures stand at 128.67% (Q1 2026), 166.89% (Q4 2025), and 69.79% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn | -128.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -128.67% |
| Dec 31, 2025 | -166.89% |
| Sep 30, 2025 | -69.79% |
| Jun 30, 2025 | -127.36% |
| Mar 31, 2025 | -129.91% |
| Dec 31, 2024 | -75.88% |
| Sep 30, 2024 | -68.52% |
| Jun 30, 2024 | -47.76% |
| Mar 31, 2024 | -110.70% |
| Dec 31, 2023 | -127.25% |
| Sep 30, 2023 | -110.27% |
| Jun 30, 2023 | -133.05% |
| Mar 31, 2023 | -129.76% |
| Dec 31, 2022 | -153.49% |
| Sep 30, 2022 | -127.34% |
| Jun 30, 2022 | -166.44% |
| Mar 31, 2022 | -182.19% |
| Dec 31, 2021 | 198.22% |
| Sep 30, 2021 | -121.05% |
| Jun 30, 2021 | -90.30% |
| Mar 31, 2021 | -98.78% |
| Dec 31, 2020 | -188.94% |
| Sep 30, 2020 | -55.21% |
| Jun 30, 2020 | -43.33% |
| Mar 31, 2020 | -80.02% |